''We are now in a far stronger position and are NOT reliant on any large pharma to take this through to registration.''
IMO
Market cap around $78m at this point in time - says a lot about how early in the game this is for measuring OS and PFS against the current best standard of care
This Latest CR is peanuts in the total upfront costs and ongoing costs and study drug costs over years
Agile Trial yet to commence on 150 plus patients initially and then towards 200 after efficacy - how many years of data will be required on varying patients trials
Newbies DYOR on registration process and costs
- Forums
- ASX - By Stock
- KZA
- KZA Media Thread
KZA Media Thread, page-988
-
-
- There are more pages in this discussion • 1,079 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)